CoreWeave (NASDAQ: CRWV) is trading at $107.73, sitting well below the $178 price target that Cantor Fitzgerald recently reiterated on the AI cloud infrastructure specialist.
The gap between the current share price and Cantor’s target represents approximately 65% in implied upside, a dislocation that Wall Street analysts are increasingly flagging as a real opportunity.
CoreWeave’s core business model centers on renting NVIDIA GPU capacity to AI labs, hyperscalers, and enterprises constructing large-scale machine learning models.
Since its March 2025 Nasdaq listing, the stock has functioned as a key proxy for the broader AI infrastructure buildout happening across the technology sector.
Q2 2026 revenue reached $2.58 billion, reflecting 112.3% growth year over year, while the company’s revenue backlog swelled to roughly $104 billion.
Despite those numbers, the stock remains down 27.58% over the trailing year, badly lagging the S&P 500, after a painful post-IPO drawdown that a recent earnings spike only partially reversed.
CoreWeave’s slide began following its Q1 2026 report in early May, when GAAP earnings per share of -$1.40 missed consensus by 16.26%, sending shares lower from $136.80 at the time of filing.
Additional headwinds include a Q4 2025 securities fraud class action alleging concealed data center construction delays, interest expense of $640 million last quarter versus $267 million a year earlier, and free cash flow of -$5.74 billion.
The Q2 2026 report, released August 11, triggered a 22.9% single-day gain, lifting shares from $87.64 to $107.73, though the stock remains down 3.22% over the trailing three months.
Cantor Fitzgerald analyst Brett Knoblauch raised his price target to $178 from $167 while reiterating an Overweight rating, anchoring his thesis on four distinct pillars supporting the bull case.
On the capacity front, CoreWeave energized roughly 450 MW in a single quarter, more than double the total capacity of its next closest specialist competitor, with management lifting the year-end capacity target by an additional 150 MW.
Revenue growth ran at approximately 130% year over year on a quarterly basis, while adjusted EBITDA doubled to $1.51 billion at a 59% margin, and management guided full-year revenue to between $12.4 billion and $13.2 billion.
Cantor estimates CoreWeave has locked in roughly 90% of its $30 billion ARR target for 2027, supported by more than $25 billion of net new customer commitments added in early Q3 2026.
Demand is also broadening beyond large hyperscaler anchor clients, with shorter-duration, higher-margin GPU instances gaining meaningful traction across the customer base.
The $178 price target reflects an 8.5x 2027 EV/EBITDA multiple, slightly lower than the prior 9.1x multiple, offset by higher operating estimates following Q2 results.
Across the broader analyst pool, 36 analysts cover CoreWeave, with 5 Strong Buy, 21 Buy, 9 Hold, 1 Sell, and 1 Strong Sell ratings, and recent revisions have skewed higher following the earnings beat.
The broader AI cloud peer group offers useful context, with Nebius Group (NASDAQ: NBIS) trading at $259.20 after a 244.09% one-year run, where the average analyst target of $250.75 now sits slightly below the current price.
IREN (NASDAQ: IREN), backed by a $3.4 billion five-year NVIDIA AI Cloud contract, trades at $43.67 and carries a 15-analyst average target of $81.73, implying approximately 87% upside.
Applied Digital (NASDAQ: APLD) trades at $31.09 with an average analyst target of $74.23, representing the widest implied upside in the peer group at roughly 139%.
CoreWeave’s valuation carries real risk given a net margin of -22.74%, a debt-to-equity ratio of 8.94, and net debt to EBITDA of 10.75, making execution on the backlog conversion critical.
With capital expenditure guided to between $35 billion and $39 billion for the year, and interest expense already running above $600 million per quarter, any tightening in capital markets access or delays in customer power delivery could quickly turn the leverage story into a liability.
The bull case ultimately depends on the $104 billion backlog converting as scheduled, higher-priced Vera Rubin SKUs ramping, managed inference ARR scaling from $100 million toward $250 million by year-end, and free cash flow turning positive as capital expenditure normalizes past 2026.
Against Cantor’s $178 target and a broader analyst consensus average of $138.37, CoreWeave presents roughly 65% upside to the Cantor case and approximately 28% upside to consensus from current trading levels.
